The National Medical Products Administration issued two guidance
documents—Guidance on Classification and Delimitation of Brain–Computer
Interface Medical Devices and Guidance on Generic Naming of Brain–Computer
Interface Medical Devices—to strengthen supervision and support high-quality
industry development. The classification guidance requires products that use BCI
technology but are not regulated as medical devices to explicitly state "not for
medical purposes" and prohibits claims that they improve, repair or replace
central nervous system functions to prevent misunderstanding or exaggerated
publicity.